Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret

Current Oncology

Volumn 19, Issue S1, 2012, Pages S37-S44

  Aning, J J ^a   Wassersug, R J ^b   Goldenberg, S Larry ^a,b  

^a VANCOUVER PROSTATE CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

decision making aids; decisional regret; partners; patient preferences; Prostate cancer

Indexed keywords

EID: 84892438488     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.1287     Document Type: Review

References (53)

1. Canadian Cancer Society’s Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2012. Toronto, ON: Canadian Cancer Society; 2012. [Available online at: http://www.cancer. ca/Canada-wide/About%20cancer/~/media/CCS/Canada%20 wide/Files%20List/English%20files%20heading/PDF%20-%20Policy%20-%20Canadian%20Cancer%20Statistics %20-%20English/Canadian%20Cancer%20Statistics%20 2012%20-%20English.ashx; cited September 19, 2012]
2. Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011;185:869–75.
3. Warde P, Mason M, Ding K, et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011;378:2104–11.
4. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126–31.
5. de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Eng J Med 2011;364:1995–2005.
6. Crook JM, O’Callaghan CJ, Duncan G, et al. Intermittent androgen suppression for rising psa level after radiotherapy. N Eng J Med 2012;367:895–903.
7. Statistics Canada. Canadian Demographics at a Glance. Catalogue 91-003. Ottawa, ON; Statistics Canada; 2008. [Available online at: http://www.statcan.gc.ca/pub/91-003-x/91-003-x2007001-eng.pdf; cited September 19, 2012]
8. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220–41.
9. Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med 1996;11:342–9.
10. Hoffman RM, Couper MP, Zikmund–Fisher BJ, et al. Prostate cancer screening decisions: results from the national survey of medical decisions (decisions study). Arch Intern Med 2009;169:1611–18.
11. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int 2002;89:255–60.
12. Snow SL, Panton RL, Butler LJ, et al. Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer. Urology 2007;69:941–5.
13. Walker LM, Tran S, Wassersug RJ, Thomas B, Robinson JW. Patients and partners lack knowledge of androgen deprivation therapy side effects. Urol Oncol 2012;:[Epub ahead of print].
14. Soeyonggo T, Warde P, Fleshner N, Timilshina N, Alibhai SM. Information needs of men on androgen deprivation therapy. BJU Int 2012;109:1503–9.
15. Deibert CM, Maliski S, Kwan L, Fink A, Connor SE, Litwin MS. Prostate cancer knowledge among low income minority men. J Urol 2007;177:1851–5.
16. Agho AO, Lewis MA. Correlates of actual and perceived knowledge of prostate cancer among African Americans. Cancer Nurs 2001;24:165–71.
17. Chapman K, Abraham C, Jenkins V, Fallowfield L. Lay understanding of terms used in cancer consultations. Psychooncology 2003;12:557–66.
18. Rot I, Ogah I, Wassersug RJ. The language of prostate cancer treatments and implications for informed decision making by patients. Eur J Cancer Care (Engl) 2012;21:766–75.
19. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: the inf luence of emotion, misconception, and anecdote. Cancer 2006;107:620–30.
20. Schul man C. Assessi ng t he at t it udes to prost ate cancer t reat ment among European male patients. BJU Int 2007;100(Suppl 1):6–11.
21. Davison BJ, Parker PA, Goldenberg SL. Patients’ preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int 2004;93:47–51.
22. Davison BJ, Gleave ME, Goldenberg SL, Degner LF, Hoffart D, Berkowitz J. Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs 2002;25:42–9.
23. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217–22.
24. Pearce A, Newcomb C, Husain S. Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer. Can Urol Assoc J 2008;2:197–203.
25. Gwede CK, Pow–Sang J, Seigne J, et al. Treatment decisionmaking strategies and influences in patients with localized prostate carcinoma. Cancer 2005;104:1381–90.
26. Sidana A, Hernandez DJ, Feng Z, et al. Treatment decisionmaking for localized prostate cancer: what younger men choose and why. Prostate 2012;72:58–64.
27. Davison BJ, Goldenberg SL. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int 2011;108:1787–93.
28. Wittmann D, He C, Coelho M, Hollenbeck B, Montie JE, Wood DP Jr. Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy. J Urol 2011;186:494–9.
29. Sommers BD, Beard CJ, D’Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 2008;113:2058–67.
30. Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int 2007;100:780–5.
31. Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 2003;97:1653–62.
32. Schroeck FR, Krupski TL, Sun L, et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 2008;54:785–93.
33. Feldman–Stewart D, Capirci C, Brennenstuhl S, et al. Information for decision making by patients with early stage prostate cancer: a comparison across 9 countries. Med Decis Making 2011;31:754–66.
34. Blinman P, King M, Norman R, Viney R, Stockler MR. Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol 2012;23:1104–10.
35. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Eng J Med 2008;358:1250–61.
36. Pearcy R, Waldron D, O’Boyle C, MacDonagh R. Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists? J R Soc Med 2008;101:133–8.
37. Elliot S, Latini DM, Walker LM, Wassersug R, Robinson JW. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med 2010;7:2996–3010.
38. Wu LM, Mohamed NE, Winkel G, Diefenbach MA. Patient and spouse illness beliefs and quality of life in prostate cancer patients. Psychol Health 2012;:[Epub ahead of print].
39. Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006;98:529–34.
40. Elwyn G, O’Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417.
41. Volk RJ, Hawley ST, Kneuper S, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med 2007;33:428–34.
42. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2011;10:CD001431.
43. Holmes–Rovner M, Stableford S, Fagerlin A, et al. Evidencebased patient choice: a prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 2005;5:16.
44. Feldman–Stewart D, Tong C, Siemens R, et al. The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making 2012;32:616–26.
45. O’Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 1998;33:267–79.
46. Berry DL, Halpenny B, Wolpin S, et al. Development and evaluation of the personal patient profile-prostate (P3P), a web-based decision support system for men newly diagnosed with localized prostate cancer. J Med Internet Res 2010;12:e67.
47. Berry DL, Halpenny B, Hong F, et al. The Personal Patient Profile–Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol 2011;:[Epub ahead of print].
48. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer 2006;106:1865–74.
49. Diefenbach M, Mohamed NE, Horwitz E, Pollack A. Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age. Psychol Health Med 2008;13:146–61.
50. Hu JC, Kwan L, Krupski TL, et al. Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology 2008;72:1274–9.
51. Diefenbach MA, Mohamed NE. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest 2007;25:449–57.
52. Berry DL, Wang Q, Halpenny B, et al. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Educ Couns 2012;88:262–7.
53. Hacking B, Wallace L, Scott S, Kosmala–Anderson J, Belkora J, McNeill A. Testing the feasibility, acceptability and effectiveness of a “decision navigation” intervention for early stage prostate cancer patients in Scotland—a randomized controlled trial. Psychooncology 2012;:[Epub ahead of print].